R932348 ophthalmic solution

R932348 · Rigel Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R932348 ophthalmic solution, covering 2016-10-03 to 2016-10-03. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca [Phase 2]

See pricing